Prospective Liver Study

This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Cancer Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Cholangiocarcinoma Digestive System Diseases Digestive System Neoplasms Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Emory University

Atlanta, Georgia, 30322, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver treatment.

Exclusion criteria

Severe liver disfunction
Active uncontrolled infection
Significant underlying medical of physical illness

Treatment and study plan

Primary outcomes

Assess efficacy of percutaneous and transarterial treatments for liver cancer.

Time frame: 1 month

QOL questionnaire will be collected during follow up visit.

Secondary outcomes

long term follow up

Time frame: 3 months, 6 months 1year

Patients will be administered QOL during 3 months, 6 months and 1 year follow up.

Sponsors and collaborators

Lead sponsor

Emory University

Other

Registry information

Official study title

Prospective Analysis of Liver Cancer Treatment and Interventions

Important dates

Study start: 2008
Primary completion: 2014
Study completion: 2014
First posted: Feb 28, 2012
Registry last updated: May 28, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed